Catalent
CTLT
$56.10
Share price
0.04%
Change (1 day)
23.49%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Number of shares outstanding for Catalent (CTLT)
Number of shares outstanding as of April 2024 : 182,000,000
According to Catalent's latest financial reports and stock price the company's current number of shares outstanding is 182,000,000. At the end of 2023 the company had 182,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Catalent from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 0.55% |
| 2022 | 0.18 B | 3.15% |
| 2021 | 0.17 B | 5.07% |
| 2020 | 0.16 B | 14.33% |
| 2019 | 0.14 B | 0.7% |
| 2018 | 0.14 B | 9.08% |
| 2017 | 0.13 B | 6.48% |
| 2016 | 0.12 B | 0.06% |
| 2015 | 0.12 B | -0.68% |
| 2014 | 0.12 B | 7.12% |
| 2013 | 0.11 B | 0% |
| 2012 | 0.11 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 54,608,963 | -70.00% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | 62,578,000 | -65.62% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | 47,819,936 | -73.73% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | 41,792,000 | -77.04% | 🇺🇸 USA |